Danny Glover reveals Alzheimer's diagnosis in effort to address disease stigma
The 79-year-old actor and activist shared his condition publicly this week, partnering with the Alzheimer's Association to highlight the disease's disproportionate impact on Black communities.

Actor and activist Danny Glover, 79, has publicly disclosed that he is living with Alzheimer's disease, stating his intention to use his diagnosis to raise public awareness. In interviews broadcast on NBC's "Today" show and published in People magazine this week, Glover confirmed he has been managing the neurodegenerative condition for several years.
According to reports, Glover received the diagnosis shortly after accepting the Jean Hersholt Humanitarian Award at the 2022 Oscars. He acknowledged that the disease has begun to affect his memory, speech, and movements, but emphasized his determination to remain active and continue engaging in his work.
Glover was joined in his public statements by his daughter, Mandisa, who noted that the family first observed changes in his memory around 2022. She stated that it was important for her father to share his experience publicly and on his own terms to control his narrative. His extended family, including his brother, is supporting him through his ongoing treatment.
In conjunction with his public disclosure, Glover has partnered with the Alzheimer's Association. The collaboration is focused on raising broader public awareness and reducing the stigma surrounding cognitive decline. A primary objective of the initiative is to highlight the disease's disproportionate impact on Black communities, where prevalence rates are notably higher.
By choosing to navigate his diagnosis openly, Glover's public efforts provide a visible platform to address the broader societal challenges of the disease. His decision to share his condition alongside the Alzheimer's Association offers a profound opportunity to destigmatize Alzheimer's disease and encourage early awareness among vulnerable populations.
Related stories

Bryan Johnson diagnosed with autoimmune gastritis amid longevity project
The tech entrepreneur known for his intensive biohacking regimen has confirmed a diagnosis of an incurable stomach condition.

Targeted antibody-drug conjugate eliminates residual B-cell acute lymphoblastic leukemia in majority of patients
Recent trial results indicate a targeted therapy has successfully eradicated remaining cancer cells in B-ALL patients, though structural challenges regarding long-term access remain.

Simultaneous postpartum and perimenopause symptoms drive reassessment of maternal care
An increasing number of women are experiencing both transitions at once, driven by later-life pregnancies and exposing a gap in current healthcare models.